| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs2270968 |
hydroxyisovaleroyl carnitine |
T/G |
5306 |
0.26 |
0.031 (0.004) |
1.31·10-16 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs2270968 |
| Chromosomal location | Chr3: 184,237,903 (3q27.1) |
| Gene (distance) | MCCC1 (0) |
| Predicted causal gene | MCCC1 |
| Gene/protein classification | - |
| Metabolite (Pathway) | hydroxyisovaleroyl carnitine (Valine, leucine and isoleucine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | Methylcrotonoyl-CoA carboxylase 1 catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown of leucine. An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA. 3-Methylcrotonyl-CoA carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine levels [19339287] |
| eQTL associations | MCCC1 (L) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | Isolated 3-methylcrotonyl-CoA carboxylase deficiency |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |